Both in Pharmaceuticals
Roivant Sciences vs United Therapeutics
Over the past year ROIV returned +92.4% and UTHR returned +39.1%; their daily moves had a correlation of 0.22.
ROIV +92.4% UTHR +39.1%Growth of $1, one year, split-adjusted
| Metric | ROIV | UTHR |
|---|---|---|
| Price | $38.23 | $608.49 |
| Market cap | $27.61B | $26.10B |
| Today | +6.08% | +1.19% |
| 1 month | +7.6% | +12.3% |
| 6 months | +32.7% | +2.0% |
| Year to date | +76.2% | +24.9% |
| 1 year | +95.1% | +38.7% |
| Revenue growth (YoY) | −33.5% | −1.9% |
| Gross margin | 100.0% | 87.3% |
| Net margin | −13164.8% | 42.5% |
| P/E (TTM) | — | 19.9× |
| Price / sales | 3,666.3× | 8.3× |
| Net cash | $3.84B | $2.66B |
| Dividend yield | — | — |
| Volatility (60d) | 50.3% | 37.1% |
| Short % of float | 8.0% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).